13F HOLDINGS REPORT
Cormorant Asset Management, LP
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001583977-23-000002
Total Value
$1.5M
Positions
72
Other Managers
1
Confidential Omitted
No
Holdings (72)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 1,655,000 | $177,615 | 11.70% |
| 2 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 6,892,101 | $147,422 | 9.71% |
| 3 | BIOMEA FUSION INC | BMEA | 3,570,872 | $110,733 | 7.29% |
| 4 | APELLIS PHARMACEUTICALS INC | APLS | 1,360,000 | $89,706 | 5.91% |
| 5 | AMBRX BIOPHARMA INC | 02290A102 | 8,500,000 | $75,820 | 4.99% |
| 6 | BRIDGEBIO PHARMA INC | BBIO | 4,557,414 | $75,562 | 4.98% |
| 7 | ARCELLX INC | ACLX | 1,600,000 | $49,296 | 3.25% |
| 8 | 89BIO INC | 282559103 | 2,800,000 | $42,644 | 2.81% |
| 9 | ENLIVEN THERAPEUTICS INC | ELVN | 1,936,133 | $42,401 | 2.79% |
| 10 | AVIDITY BIOSCIENCES INC | 05370A108 | 2,612,115 | $40,096 | 2.64% |
| 11 | PROTAGONIST THERAPEUTICS INC | PTGX | 1,700,000 | $39,100 | 2.58% |
| 12 | PLIANT THERAPEUTICS INC | PLRX | 1,444,000 | $38,410 | 2.53% |
| 13 | ERASCA INC | ERAS | 10,813,246 | $32,548 | 2.14% |
| 14 | AEROVATE THERAPEUTICS INC | 008064107 | 1,561,696 | $31,499 | 2.07% |
| 15 | DESIGN THERAPEUTICS INC | DSGN | 5,150,000 | $29,716 | 1.96% |
| 16 | RAIN ONCOLOGY INC | 75082Q105 | 2,978,660 | $26,033 | 1.71% |
| 17 | IMMUNEERING CORP | IMRX | 2,386,181 | $23,170 | 1.53% |
| 18 | MONTE ROSA THERAPEUTICS INC | GLUE | 2,893,717 | $22,542 | 1.48% |
| 19 | VIRIDIAN THERAPEUTICS INC | VRDN | 850,000 | $21,624 | 1.42% |
| 20 | VECTIVBIO HLDG AG | H9060V101 | 2,536,617 | $21,587 | 1.42% |
| 21 | EDGEWISE THERAPEUTICS INC | EWTX | 2,946,887 | $19,656 | 1.29% |
| 22 | AXSOME THERAPEUTICS INC | AXSM | 300,000 | $18,504 | 1.22% |
| 23 | TARSUS PHARMACEUTICALS INC | TARS | 1,421,422 | $17,867 | 1.18% |
| 24 | AXONICS INC | 05465P101 | 322,240 | $17,581 | 1.16% |
| 25 | VIKING THERAPEUTICS INC | VKTX | 1,050,000 | $17,483 | 1.15% |
| 26 | TANGO THERAPEUTICS INC | TNGX | 4,116,949 | $16,262 | 1.07% |
| 27 | SAREPTA THERAPEUTICS INC | SRPT | 110,000 | $15,161 | 1.00% |
| 28 | CABALETTA BIO INC | CABA | 1,821,739 | $15,066 | 0.99% |
| 29 | ROCKET PHARMACEUTICALS INC | RCKTW | 868,550 | $14,878 | 0.98% |
| 30 | KARUNA THERAPEUTICS INC | 48576A100 | 80,000 | $14,531 | 0.96% |
| 31 | STRUCTURE THERAPEUTICS INC | GPCR | 576,373 | $13,712 | 0.90% |
| 32 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,000,000 | $13,300 | 0.88% |
| 33 | MORPHIC HLDG INC | 61775R105 | 325,000 | $12,233 | 0.81% |
| 34 | RAPT THERAPEUTICS INC | 75382E109 | 650,000 | $11,928 | 0.79% |
| 35 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,271,429 | $11,087 | 0.73% |
| 36 | OLEMA PHARMACEUTICALS INC | OLMA | 3,082,000 | $10,695 | 0.70% |
| 37 | CYTOKINETICS INC | CYTK | 296,000 | $10,416 | 0.69% |
| 38 | VAXCYTE INC | PCVX | 275,000 | $10,307 | 0.68% |
| 39 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 2,353,141 | $9,436 | 0.62% |
| 40 | STOKE THERAPEUTICS INC | STOK | 1,087,807 | $9,061 | 0.60% |
| 41 | PRIME MEDICINE INC | PRME | 734,350 | $9,033 | 0.59% |
| 42 | LIANBIO | LIANY | 4,250,000 | $8,330 | 0.55% |
| 43 | COGENT BIOSCIENCES INC | COGT | 700,000 | $7,553 | 0.50% |
| 44 | PHARVARIS N V | PHVS | 816,460 | $6,577 | 0.43% |
| 45 | VIGIL NEUROSCIENCE INC | 92673K108 | 616,786 | $6,038 | 0.40% |
| 46 | ATEA PHARMACEUTICALS INC | AVIR | 1,547,181 | $5,183 | 0.34% |
| 47 | VERVE THERAPEUTICS INC | 92539P101 | 350,000 | $5,047 | 0.33% |
| 48 | ANNEXON INC | ANNX | 1,250,000 | $4,813 | 0.32% |
| 49 | IDEAYA BIOSCIENCES INC | IDYA | 350,000 | $4,806 | 0.32% |
| 50 | GH RESEARCH PLC | GHRS | 593,043 | $4,738 | 0.31% |
| 51 | GREENLIGHT BIOSCIENCS HLDS P | 39536G105 | 9,188,659 | $3,973 | 0.26% |
| 52 | ICOSAVAX INC | 45114M109 | 643,825 | $3,734 | 0.25% |
| 53 | ELEVATION ONCOLOGY INC | 28623U101 | 1,952,032 | $3,709 | 0.24% |
| 54 | BIOATLA INC | BCAB | 1,181,115 | $3,165 | 0.21% |
| 55 | FULCRUM THERAPEUTICS INC | FULC | 1,081,490 | $3,082 | 0.20% |
| 56 | POSEIDA THERAPEUTICS INC | 73730P108 | 1,000,000 | $3,080 | 0.20% |
| 57 | ELEDON PHARMACEUTICALS INC | ELDN | 1,217,882 | $2,874 | 0.19% |
| 58 | ALX ONCOLOGY HLDGS INC | ALXO | 612,079 | $2,767 | 0.18% |
| 59 | CENTESSA PHARMACEUTICALS PLC | CNTA | 561,600 | $2,162 | 0.14% |
| 60 | GALECTO INC | 36322Q107 | 1,020,238 | $2,030 | 0.13% |
| 61 | TALARIS THERAPEUTICS INC | 87410C104 | 900,649 | $1,693 | 0.11% |
| 62 | X4 PHARMACEUTICALS INC | XFOR | 1,628,980 | $1,417 | 0.09% |
| 63 | BIOHAVEN LTD | BHVN | 81,963 | $1,120 | 0.07% |
| 64 | PYXIS ONCOLOGY INC | PYXS | 272,537 | $1,093 | 0.07% |
| 65 | AUTOLUS THERAPEUTICS PLC | AUTL | 392,167 | $722 | 0.05% |
| 66 | EYEPOINT PHARMACEUTICALS INC | EYPT | 225,065 | $662 | 0.04% |
| 67 | LEAP THERAPEUTICS INC | 52187K101 | 1,481,511 | $504 | 0.03% |
| 68 | GRAPHITE BIO INC | 38870X104 | 199,547 | $489 | 0.03% |
| 69 | CHEMOMAB THERAPEUTICS LTD | CMMB | 288,169 | $458 | 0.03% |
| 70 | HARPOON THERAPEUTICS INC | 41358P106 | 540,600 | $402 | 0.03% |
| 71 | ATRECA INC | 04965G109 | 319,057 | $364 | 0.02% |
| 72 | ORCHARD THERAPEUTICS PLC | 68570P200 | 25,664 | $138 | 0.01% |